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Cutting Edge: Neosynthesis Is Required for the
Presentation of a T Cell Epitope from a Long-Lived
Viral Protein1
Selina Khan,* Rita de Giuli,* Gunter Schmidtke,* Michael Bruns,†
Michael Buchmeier,‡ Maries van den Broek,§ and Marcus Groettrup2*
CTLs recognize peptide epitopes which are proteolytically gen-
erated by the proteasome and presented on MHC class I mol-
ecules. According to the defective ribosomal product (DRiP)
hypothesis, epitopes originate from newly synthesized polypep-
tides which are degraded shortly after their translation. The
DRiP hypothesis would explain how epitopes can be generated
from long-lived proteins. We examined whether neosynthesis is
required for presentation of the immunodominant epitope
NP118 of the lymphocytic choriomeningitis virus nucleopro-
tein, which has a half-life of >3 days. Two days after nucleo-
protein biosynthesis was terminated in a tetracycline-regulated
transfectant, the presentation of the NP118 epitope ceased.
This indicates that NP118 epitopes are generated from newly
synthesized nucleoproteins rather than from the long-lived
pool of nucleoproteins in the cell. Therefore, the lymphocytic
choriomeningitis virus nucleoprotein is the first substrate for
which a major prediction of the DRiP hypothesis, namely the
requirement for neosynthesis, is shown to hold true. The
Journal of Immunology, 2001, 167: 4801–4804.
T he MHC class I pathway allows CTLs to monitor theprotein content of virtually all cells of our body and, ifproperly activated, to eliminate those cells which contain
immunogenic proteins. A prerequisite for the recognition of patho-
gen-encoded proteins is that the protein is degraded at such a rate
that sufficient class I ligands are produced. It is therefore not only
the steady state concentration of an intracellular protein but also its
rate of degradation and the efficiency of processing which deter-
mines epitope production. The essential role of protein catabolism
for Ag presentation in the class I compartment is evident because
Ag presentation is abrogated when cells are treated with inhibitors
of the proteasome, a proteolytic complex which is crucially in-
volved in epitope generation. However, most intracellular proteins
are rather long-lived, and viruses encode structural proteins which
are degraded at a low rate. The nucleoprotein of lymphocytic cho-
riomeningitis virus (LCMV)3 is an example of a very stable pro-
tein which nevertheless gives rise to immunodominant epitopes,
such as the H-2Ld restricted NP118 epitope, which is the main
target of LCMV-specific CTLs in BALB/c mice. Despite the long
half-life of the LCMV nucleoprotein, the generation of the NP118
epitope is abolished by proteasome inhibitors (1).
A possible solution to this apparent paradox is the defective
ribosomal products (DRiP) hypothesis, which states that epitopes
are not necessarily derived from the degradation of mature and
appropriately folded proteins, but may be processed from newly
translated polypeptides which are rapidly degraded because they
fail to acquire their natively folded state (2). Consistent with this
hypothesis, it has recently been shown that about one-third of
newly synthesized proteins are degraded within 15 min after their
biogenesis (3). Moreover, the peptide-dependent maturation of
class I molecules in the endoplasmic reticulum was slowed down
when translation was suppressed with protein synthesis inhibitors.
The latter experiment suggested that a substantial portion of MHC
class I peptide ligands are derived from proteins which were syn-
thesized and degraded within a period of 90 min. This concept
gained further support through the demonstration that the activity
of the TAP largely depends on protein neosynthesis (4). However,
it should be pointed out that these experiments were performed in
the presence of protein synthesis inhibitors which may not be rep-
resentative for the physiological situation. Moreover, an example
of a DRiP substrate has not been identified so far. Therefore, we
investigated the long-lived LCMV nucleoprotein as a potential
DRiP substrate. By expressing the nucleoprotein in an inducible
manner we could demonstrate that NP118 presentation relies on
protein neosynthesis, which is a property anticipated by the DRiP
hypothesis.
Materials and Methods
Antibodies
The mAbs used in this study were KL25 specific for the LCMV glyco-
protein GP1 and KL53 specific for the LCMV nucleoprotein (5).
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Cell lines
B8 is a BALB/c-derived fibroblast line obtained by SV40 infection in vitro
(5). The T cell hybridoma LCMV-NP118 is specific for the NP118 epitope
of LCMV (5) and T2-Ld is an H-2Ld transfectant of the TAP-deficient
lymphoblastoid line T2. The cells were grown in IMDM supplemented
with 10% FCS, 2 mM L-glutamine, and 100 U/ml penicillin/streptomycin.
LCMV and infection of cell lines
LCMV-WE strain was grown and titrated on L929 cells as previously
described (5). The infection of 107 cells in vitro was performed at a mul-
tiplicity of infection of 0.05 in RPMI 1640 medium without FCS in a
volume of 1 ml under agitation at room temperature for 30 min. Subse-
quently, the cells were plated in complete growth medium.
Generation of the pTet-SpliceLCMV-NP construct
The LCMV-WE cDNA was cloned into the tetracycline (tet)-regulated
expression construct pTet-Splice (6) via EcoRI and SpeI sites, thus yielding
the plasmid pTet-SpliceLCMV-NP.
Transfections
B8 cells were cotransfected by calcium phosphate precipitation with the
pTet-tTAk plasmid encoding the tet-responsive inductor (6) and the
pLXSH plasmid encoding a hygromycin resistance gene. Clones were se-
lected with hygromycin B (400 g/ml) in medium containing 1 g/ml tet.
The presence of pTet-tTAk was confirmed by genomic PCR analysis using
the oligonucleotides 5-ATGTCTAGATTAGATAAAAGTAAAG-3 and
5-CTACCCACCGTACTCGTCAA-3, specific for the coding sequence
of the transactivator gene. B8tTA.F4, a clone which showed high tTAk
expression in the absence of tet but very low expression in the presence of
tet was selected for supertransfections. B8tTA.F4 cells were transfected
with pTet-SpliceLCMV-NP and the pLXSP plasmid encoding a puromycin
resistance gene. Puromycin-resistant clones were cultured in IMDM sup-
plemented with 10% FCS, 100 U/ml penicillin/streptomycin, 400 g/ml
hygromycin, 5 g/ml puromycin, and 1 g/ml tet. The integration of the
pTet-SpliceLCMV-NP construct into the genome was confirmed by
genomic PCR using oligonucleotides 5-AGAAAGGAAAGGAGGGAC
GATA-3 and 5-TGAATTGCTTCTGGTCCGTAG-3.
Cytolytic assay and hybridoma assay
As target cell we used unpulsed B8 cells or B8 cells loaded with the NP118
peptide RPQASGVYM at 107 M in PBS for 1 h. Splenocytes from a
BALB/c mouse which had been infected 8 days before with 200 pfu of
LCMV-WE i.v. were used as effectors in chromium release assays. Load-
ing of target cells with chromium and performance of the cytolytic assay
were exactly as previously described (5). The hybridoma/lacZ assay was
performed with the LCMV-NP118-specific T cell hybridoma as outlined
elsewhere (5).
Metabolic labeling and immunoprecipitation
B8 cells were either left uninfected or were infected with LCMV-WE 24 h
before metabolic labeling. B8tNP64 cells were grown in the presence or
absence of 1 g/ml tet at least 5 days before labeling. Cells were
labeled with [35S]methionine/[35S]cysteine for 3 h, chased for indicated
time periods, and immunoprecipitated with mAb KL53 as previously
described (1).
Northern blot
Total RNA was extracted from cells using TRIzol Reagent (Life Technol-
ogies, Basel, Switzerland), separated on agarose formaldehyde gels, trans-
ferred to a membrane, and radioactively probed as described elsewhere (7).
32P-Labeled probes were generated on nucleoprotein and hypoxanthine-
guanine phosphoribosyltransferase (HPRT) cDNA templates using random
primers as well as the specific primers HPRT1 (5-CACAGGACTAGAA
CACCTGC-3), HPRT2 (5-GCTGGTGAAAAGGACCTCT-3), NP1 (5-
GAGAAGCTGAAGGCCAAAAT-3), and NP2 (5-CGCACCAAGAC
TGAAATTATA-3).
Results
The LCMV nucleoprotein is a very long-lived protein in LCMV-
infected cells and in a tet-regulated nucleoprotein transfectant
LCMV is a small ()-strand RNA virus which consists of only
two structural proteins, the glycoprotein and the nucleoprotein.
Previously we observed during pulse chase experiments that the
half-life of the nucleoprotein is much longer than that of the glyco-
protein (1). To determine the degradation rate of the LCMV nu-
cleoprotein in B8 mouse fibroblast cells, these cells were infected
with the WE strain of LCMV, and after 1 day of infection the cells
were metabolically labeled and chased over a period of 3 days.
Remarkably, no evidence for a degradation of the LCMV nucleo-
protein could be obtained within 3 days (Fig. 1A).
To investigate the role of protein neosynthesis for the presen-
tation of the nucleoprotein epitope NP118, we generated a trans-
fectant of B8 cells in which the nucleoprotein is expressed from a
tet-regulated promoter. Initially, B8 cells were stably transfected
with the expression construct pTet-tTAk, which encodes a tet-re-
sponsive transcriptional inducer (6). The transfectants were tested
by transient supertransfection of tet-regulated -galactosidase or
luciferase reporter constructs, and a clone designated B8tTA.F4
was chosen for additional experiments. This clone was stably su-
pertransfected with the plasmid pTet-SpliceLCMV-NP, which
contains the full-length cDNA of the LCMV-WE nucleoprotein
under the control of a tet-repressible promoter (6). Transfectants
were prescreened with genomic PCR, and a clone, designated
B8tNP64, which presented the NP118 epitope in the absence but
not in the presence of tet (Fig. 4A), was selected for further
analysis.
The degradation rate of the LCMV nucleoprotein was deter-
mined in the B8tNP64 clone in a pulse chase experiment (Fig. 1B).
A quantification of the nucleoprotein immunoprecipitates from
LCMV-WE-infected B8 cells and the B8tNP64 clone in the ab-
sence of tet showed that the amount of nucleoprotein was about
eightfold lower in B8tNP64 cells. The expression of the nucleo-
protein in B8tNP64 cells is completely suppressed in the presence
of tet, as evidenced in the third lane of Fig. 1B. Similar to what we
had observed in LCMV-WE-infected B8 cells, the half-life of the
nucleoprotein in B8tNP64 cells is longer than 3 days. It should be
noted that the pulse chase experiment with B8tNP64 cells was
performed such that tet was added to the growth medium during
the chase, thus preventing nucleoprotein neosynthesis during the
chase period.
FIGURE 1. The LCMV nucleoprotein (NP) is degraded at a very low
rate. A, B8 fibroblasts were either left uninfected (uninf.) or infected with
LCMV-WE for 24 h before being metabolically labeled and chased for the
indicated time periods. B, Pulse chase experiment of nucleoprotein expres-
sion in the tet-regulated nucleoprotein transfectant B8tNP64. B8tNP64
cells were grown for 5 days in the presence (tet) or absence (tet) of tet.
For / tet samples, cells were grown and metabolically labeled with 35S
in the absence but chased in the presence of tet to avoid nucleoprotein
synthesis during the chase. Uninfected and LCMV-infected B8 cells were
used as controls.
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Determination of the half-life of nucleoprotein mRNA in tet-
regulated transfectants and of H-2Ld/NP118 complexes on the
cell surface
To determine the role of nucleoprotein neosynthesis for NP118
presentation it was important to investigate how long the mRNA
for the nucleoprotein would persist in B8tNP64 transfectants after
the cells were treated with tet. The Northern blot shown in Fig. 2
illustrates that B8tNP64 cells which had been grown for 5 days in
the presence of tet do not express nucleoprotein mRNA (Fig. 2,
lane 1). When the clone was grown for 5 days in the absence of tet
the nucleoprotein mRNA was readily detected in B8tNP64 cells
(Fig. 2, lane 2). The amount of nucleoprotein mRNA in B8tNP64
cells was about eightfold lower than in B8 cells which had been
infected with LCMV-WE for 2 days, a result which is in accor-
dance with the quantification of nucleoprotein immunoprecipitates
(Fig. 1B) which had been performed with aliquots of the same
cells. Only 24 h after the addition of tet to these cells (Fig. 2, lane
3) nucleoprotein mRNA was not detectable anymore, indicating
that the tet-mediated ablation of nucleoprotein transcription was
rapid and the nucleoprotein mRNA in B8tNP64 cells was degraded
within 1 day. Consistently, we could not detect nucleoprotein neo-
synthesis in metabolic labeling and immunoprecipitation experi-
ments after cells had been treated with tet for 6, 24, 48, 72, or 96 h
(data not shown).
Another factor which affects the duration of Ag presentation
after shutting off nucleoprotein neosynthesis is the half-life of
H-2Ld/NP118 complexes on the cell surface. We determined by
flow cytometry how long the NP118 synthetic nonamer would be
able to stabilize H-2Ld complexes on the surface of T2-Ld cells.
The loss of H-Ld/NP118 complexes from the cell surface was com-
plete after 16 h of incubation at 37°C (data not shown), indicating
that for the stimulation of T cells new supply of epitopes is re-
quired after this time period.
Neosynthesis of the LCMV nucleoprotein is required for the
presentation of the NP118 epitope
To determine how the tet-mediated ablation of synthesizing nu-
cleoprotein mRNA and, as a consequence, of the nucleoprotein
itself would affect NP118 presentation in B8tNP64 cells, we per-
formed lacZ assays based on the activation of the H-2Ld/NP118-
specific T cell hybridoma LCMV-NP118 (5). In a first experiment
we tested the specificity of the hybridoma, which reacted with
NP118-pulsed B8 cells and with B8tNP64 cells grown in the ab-
sence of tet but not with unpulsed B8 cells or B8tNP64 cells grown
in the presence of tet (Fig. 3A). Moreover, we established that
NP118 presentation on LCMV-infected B8 cells was not affected
by tet (data not shown). Next, we monitored NP118 presentation
on B8tNP64 cells which had been grown in the absence of tet and
were subsequently cultivated for 0, 1, 2, and 3 days in the presence
of tet (Fig. 3B). Only 1 day after cultivation with tet, NP118 pre-
sentation was reduced by 50%, and on the second day of tet treat-
ment the NP118 presentation was at background levels obtained
with uninfected B8 cells. Aliquots of the same B8tNP64 cells used
as stimulators in this experiment were used in parallel for the im-
munoprecipitation and Northern blot analysis shown in Fig. 1B and
Fig. 2, respectively. It is therefore evident that nucleoprotein neo-
synthesis is required to maintain NP118 presentation and that the
presentation of this epitope cannot be fueled from the long-lived
nucleoprotein molecules, which remained at the same level in
B8tNP64 over 3 days. The same conclusion was reached in an
independent experiment when NP118 presentation was monitored
in a cytolytic assay with LCMV-specific primary CTLs as effectors
(Fig. 4). Even with this very sensitive read-out system, a sharp
drop in NP118 presentation was detected 1 day after the termina-
tion of nucleoprotein synthesis in B8tNP64 cells and no residual
NP118 presentation remained on the third day of cultivation in the
presence of tet. Taken together, our data clearly demonstrate a
requirement for nucleoprotein neosynthesis for the presentation of
the immunodominant epitope NP118.
FIGURE 2. Northern blot analysis of LCMV nucleoprotein mRNA con-
tent in LCMV-infected B8 cells and in the tet-regulated nucleoprotein
transfectant B8tNP64. Cells were grown in the presence (tet) or absence
(tet) of tet. In the case of / tet samples, B8tNP64 cells had been
cultivated without tet and were then grown in the presence of tet for the
indicated time periods. Total RNA was blotted and hybridized with 32P-
labeled LCMV nucleoprotein and HPRT probes. The small size difference
between the viral and vector derived mRNAs is probably due to untrans-
lated regions of different length.
FIGURE 3. Analysis of NP118 presentation by B8tNP64 cells with a T
cell hybridoma-based lacZ assay. Activation of the LCMV-NP118 hybrid-
oma leads to -galactosidase production, which is measured in a chromo-
genic assay. A, Comparison of NP118 presentation by untreated or NP118
peptide-loaded B8 cells with B8tNP64 cells grown in the absence or pres-
ence of tet. B, NP118 presentation was determined for B8tNP64 cells
which had been cultured in the absence of tet and were then grown in the
presence of tet for the indicated number of days (/ tet, filled bars). For
each assay day, B8tNP64 cells which had been grown in the absence (tet)
or presence (tet) of tet were used as controls. The data represent means
and SEM of triplicate values.
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Discussion
In this work we tried to reconcile two paradoxical experimental
findings. On the one hand, the LCMV nucleoprotein contains two
immunodominant T cell epitopes which are presented in a protea-
some-dependent manner (1). On the other hand, the nucleoprotein
is a long-lived protein which is not detectably degraded within a
period of 3 days. Two hypotheses have been proposed which could
resolve the apparent paradox. The first hypothesis is the peptone
hypothesis proposed in 1989 by Boon and Van Pel (8). It suggests
that class I ligands may stem from polypeptides (peptons) which
were translated from short RNAs generated randomly by promot-
er- and frame-independent transcriptional events. This hypothesis
is inconsistent with our results because NP118 presentation corre-
lates strictly with the activation of the tet-repressible promoter
which drives nucleoprotein transcription. The second hypothesis is
the DRiP hypothesis put forward in 1996 by Yewdell et al. (2). It
states that T cell epitopes are derived from defective ribosomal
products which are not translated or folded properly and are de-
graded shortly after their synthesis. A critical aspect of this hy-
pothesis, namely the requirement of neosynthesis for class I-re-
stricted presentation, is in accordance with our results. Whether
some or all of these rapidly degraded nucleoproteins are defective
or whether they were translated correctly but simply did not fold
fast enough to escape degradation has not been addressed in the
present study and remains to be determined.
Although we cannot rule out that a minor contribution to the
pool of NP118 epitopes stems from the catabolism of preexisting
and long-lived nucleoproteins, this supply is clearly insufficient to
be recognized by NP118-specific CTLs. Hence, the NP118-spe-
cific CTL response will lyse only those cells which actively syn-
thesize the nucleoprotein, and cells which managed to suppress the
transcription and translation of the LCMV nucleoprotein with help
of antiviral cytokines like IFN- and IFN- may escape lysis and
irreversible destruction through CTLs.
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FIGURE 4. Cytolytic chromium release assay of NP118 presentation by
B8tNP64 cells. Target cells were the same as in Fig. 3; effector cells were
splenocytes from a BALB/c mouse on day 8 after LCMV-WE infection. A,
Comparison of NP118 presentation by untreated or NP118 peptide-loaded
B8 cells with B8tNP64 cells grown in the absence or presence of tet. B,
Kinetic of NP118 presentation on different days after termination of nu-
cleoprotein synthesis through the addition of tet as outlined in Fig. 3. Val-
ues represent means of triplicates.
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